IL116617A - Monoclonal antibody 4g9, 2g6 or bh4, or an antigen binding fragment thereof reactive with in vivo produced advanced glycosylation endproducts - Google Patents

Monoclonal antibody 4g9, 2g6 or bh4, or an antigen binding fragment thereof reactive with in vivo produced advanced glycosylation endproducts

Info

Publication number
IL116617A
IL116617A IL11661795A IL11661795A IL116617A IL 116617 A IL116617 A IL 116617A IL 11661795 A IL11661795 A IL 11661795A IL 11661795 A IL11661795 A IL 11661795A IL 116617 A IL116617 A IL 116617A
Authority
IL
Israel
Prior art keywords
age
monoclonal antibody
ages
antibody
binding fragment
Prior art date
Application number
IL11661795A
Other languages
English (en)
Other versions
IL116617A0 (en
Original Assignee
Alteon Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/367,507 external-priority patent/US5744318A/en
Application filed by Alteon Inc filed Critical Alteon Inc
Publication of IL116617A0 publication Critical patent/IL116617A0/xx
Publication of IL116617A publication Critical patent/IL116617A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/975—Kit

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
IL11661795A 1994-12-30 1995-12-29 Monoclonal antibody 4g9, 2g6 or bh4, or an antigen binding fragment thereof reactive with in vivo produced advanced glycosylation endproducts IL116617A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/367,507 US5744318A (en) 1994-12-30 1994-12-30 Monoclonal antibody for the detection of advanced glycosylation endproducts in biological samples
US08/483,186 US5698197A (en) 1994-12-30 1995-06-07 Monoclonal antibody specific for advanced glycosylation endproducts in biological samples
US08/581,724 US5892000A (en) 1994-12-30 1995-12-29 Monoclonal antibodies specific for advanced glycosylation endproducts in biological samples

Publications (2)

Publication Number Publication Date
IL116617A0 IL116617A0 (en) 1996-09-12
IL116617A true IL116617A (en) 2001-09-13

Family

ID=27408819

Family Applications (1)

Application Number Title Priority Date Filing Date
IL11661795A IL116617A (en) 1994-12-30 1995-12-29 Monoclonal antibody 4g9, 2g6 or bh4, or an antigen binding fragment thereof reactive with in vivo produced advanced glycosylation endproducts

Country Status (10)

Country Link
US (2) US5892000A (de)
EP (1) EP0801658B1 (de)
JP (1) JP2002514888A (de)
AT (1) ATE245169T1 (de)
AU (1) AU693992B2 (de)
CA (1) CA2208411A1 (de)
DE (1) DE69531311T2 (de)
ES (1) ES2203651T3 (de)
IL (1) IL116617A (de)
WO (1) WO1996020958A1 (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997024372A1 (en) * 1995-12-29 1997-07-10 Alteon Inc. 6-(n-carboxymethylamino)caproate, salts thereof and methods of use therefor
US7071298B2 (en) * 1997-02-05 2006-07-04 Fox Chase Cancer Center Compounds and methods for treating glycogen storage disease and other pathological conditions resulting from formation of age-proteins
JPH11258238A (ja) * 1998-03-10 1999-09-24 Tokuyama Corp 免疫学的凝集測定用試薬キット
WO1999064463A1 (en) * 1998-06-09 1999-12-16 Alteon Inc. Monoclonal antibodies specific for guanidino group-derived advanced glycosylation endproducts in biological samples
FR2798735B1 (fr) * 1999-09-17 2001-11-23 Serobiologiques Lab Sa Procede d'evaluation et de suivi du vieillissement tissulaire
KR20120127543A (ko) * 2008-05-23 2012-11-21 시와 코퍼레이션 재생을 촉진하는 방법, 조성물 및 장치
ES2725852T3 (es) 2010-09-27 2019-09-27 Siwa Corp Eliminación selectiva de células modificadas por AGE para el tratamiento de la aterosclerosis
US8721571B2 (en) 2010-11-22 2014-05-13 Siwa Corporation Selective removal of cells having accumulated agents
CA2961603C (en) 2014-09-19 2021-07-13 Siwa Corporation Anti-age antibodies for treating inflammation and auto-immune disorders
US10358502B2 (en) 2014-12-18 2019-07-23 Siwa Corporation Product and method for treating sarcopenia
US9993535B2 (en) 2014-12-18 2018-06-12 Siwa Corporation Method and composition for treating sarcopenia
JP6722293B2 (ja) 2016-02-19 2020-07-15 シワ コーポレーション 終末糖化産物（ａｇｅ）に対する抗体を使用して、がんを治療、転移性がん細胞を殺傷、及びがん転移を予防するための方法及び組成物
CA3057829A1 (en) 2016-04-15 2017-10-19 Siwa Corporation Anti-age antibodies for treating neurodegenerative disorders
JP2019518763A (ja) 2016-06-23 2019-07-04 シワ コーポレーション 様々な疾患及び障害の治療において使用するためのワクチン
US10961321B1 (en) 2017-01-06 2021-03-30 Siwa Corporation Methods and compositions for treating pain associated with inflammation
US10858449B1 (en) 2017-01-06 2020-12-08 Siwa Corporation Methods and compositions for treating osteoarthritis
US10995151B1 (en) 2017-01-06 2021-05-04 Siwa Corporation Methods and compositions for treating disease-related cachexia
US10925937B1 (en) 2017-01-06 2021-02-23 Siwa Corporation Vaccines for use in treating juvenile disorders associated with inflammation
BR112019021471A2 (pt) 2017-04-13 2020-05-12 Siwa Corporation Anticorpo monoclonal humanizado de produto final da glicação avançada
US11518801B1 (en) 2017-12-22 2022-12-06 Siwa Corporation Methods and compositions for treating diabetes and diabetic complications
CN110208543A (zh) * 2019-06-06 2019-09-06 威海威高生物科技有限公司 血管内皮生长因子检测试剂盒及其使用方法和应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5869534A (en) * 1992-05-21 1999-02-09 The Picower Institute For Medical Research Glycosylation of lipids and lipid-containing particles, and diagnostic and therapeutic methods and materials derived therefrom
US5624804A (en) * 1991-12-20 1997-04-29 The Rockefeller University Immunochemical detection of In vivo advanced glycosylation end products

Also Published As

Publication number Publication date
ES2203651T3 (es) 2004-04-16
EP0801658B1 (de) 2003-07-16
ATE245169T1 (de) 2003-08-15
WO1996020958A1 (en) 1996-07-11
CA2208411A1 (en) 1996-07-11
EP0801658A1 (de) 1997-10-22
US5892000A (en) 1999-04-06
IL116617A0 (en) 1996-09-12
DE69531311D1 (de) 2003-08-21
DE69531311T2 (de) 2004-04-22
AU693992B2 (en) 1998-07-09
AU4648396A (en) 1996-07-24
USRE39138E1 (en) 2006-06-20
JP2002514888A (ja) 2002-05-21

Similar Documents

Publication Publication Date Title
US5698197A (en) Monoclonal antibody specific for advanced glycosylation endproducts in biological samples
US5892000A (en) Monoclonal antibodies specific for advanced glycosylation endproducts in biological samples
WO1996020958A9 (en) Monoclonal antibodies specific for advanced glycosylation endproducts in biological samples
KR100257733B1 (ko) 생체내 개량된 글리코실화 종말 산물의 면역 화학적 검출용 시험키트
JP3441763B2 (ja) モノクローナル抗体及び該モノクローナル抗体を用いたヒトｇ−ｃｓｆの測定法
JPH02503059A (ja) 抗グリコシルアルブミンモノクロナル抗体とそれらの抗体を産生するハイブリッド細胞株、およびその使用
EP0312540B1 (de) Monoklonale antikörper gegen nicht reduzierte, nicht enzymatisch glykolysierte proteine
WO1999064463A1 (en) Monoclonal antibodies specific for guanidino group-derived advanced glycosylation endproducts in biological samples
JP4016304B2 (ja) モノクローナル抗体、ハイブリッド細胞、およびモノクローナル抗体の製造方法
JP4234207B2 (ja) アレルギー性気管支肺アスペルギルス症の診断方法
EP2159577A1 (de) Neuer marker für arteriosklerosekrankheit
JP2007277263A (ja) カルボキシメチル化タンパク質に対する抗体
US5955582A (en) Antibody against a 3-aminophenylboronic-glycated protein complex and its use in an immunoassay
CA2365666A1 (en) Method for detecting deficient cellular membrane tightly bound magnesium for disease diagnoses
US5869527A (en) 6-(N-carboxymethylamino)caproate, salts thereof and methods of use therefor
EP0444787B1 (de) Monoklonale Antikörper gegen nicht-A 1C glykosyliertes Hämoglobin
JP4013312B2 (ja) モノクローナル抗体およびハイブリッド細胞
WO1997024372A1 (en) 6-(n-carboxymethylamino)caproate, salts thereof and methods of use therefor
JP3542227B2 (ja) 免疫試薬
JP2762058B2 (ja) カルボニル化合物− タンパク質複合体の定量法

Legal Events

Date Code Title Description
MM9K Patent not in force due to non-payment of renewal fees